Add Company
Join Now

SERB Pharmaceuticals Revenue and Competitors

License our Company Data API

Brussels, Bel

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • SERB Pharmaceuticals's estimated annual revenue is currently $88.4M per year.(i)
  • SERB Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • SERB Pharmaceuticals has 440 Employees.(i)
  • SERB Pharmaceuticals grew their employee count by 23% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$24.3M1216%N/AN/A
#2
$29.9M14910%N/AN/A
#3
$29.1M1459%N/AN/A
#4
$44.8M223-2%N/AN/A
#5
$28.9M144-5%N/AN/A
#6
$64.7M32210%N/AN/A
#7
$43.2M21537%N/AN/A
#8
$64.7M32210%N/AN/A
#9
$88.4M44023%N/AN/A
#10
N/A5743%N/AN/A
Add Company

What Is SERB Pharmaceuticals?

SERB is a growing pharmaceutical company and a dedicated ally to healthcare providers treating patients with critical conditions, focusing on emergency care and rare diseases. For over 30 years we have made treating these complex and life-threatening conditions possible; supporting clinicians, healthcare systems and governments while offering hope to patients and their families. As a fully integrated company, we have the experience and capabilities to acquire, develop, and manufacture our medicines to the highest standards, and make them available worldwide through our secure supply chain. SERB operates in the US as BTG Pharmaceuticals.

keywords:N/A

N/A

Total Funding

440

Number of Employees

$88.4M

Revenue (est)

23%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$88.4M4428%N/A
#2
$162.3M48177%N/A
#3
$117.6M5779%N/A
#4
$187.6M59112%N/A
#5
$187.6M59112%N/A